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Neutral endopeptldase (EC 3.4.24 11: NEP) 1s a membrane-bound zinc-metallopeptldase. The catalytic zmc eon 1s coordmated to three ammo acid 
residues (HIs”~, His”’ and GIL?) and a water molecule Here. we have systematlcally substituted potential metal-coordmating ammo acid residues 
(His. Glu, Asp, Cys. Tqr, Ser) for each of the three zmc hgands of NEP using a recombinant polqmerase chain reaction procedure. NEP mutants 
at positlons 583 and 587 were devoid of catalytic actlrity. However. GIu~~ NEP and Cys “’ NEP were able to bmd partially a trltlated inhlbitor, 
the binding of which is dependent on the presence of the zinc atom. At posltlon 646, the aspartate and cysteine mutants exhibited activity. For 
both mutants K,,, values were unaltered but li,,,, values were decreased by about 20-fold. Both mutants bound the trmated Inhibitor with Kd values 
slmllar to that of the wild-type enzyme. Our data suggest that neither histldme-583 nor -587 can be replaced by any other hgands. On the other 
hand. the glutamic acid at posltion 646 can be converted to an aspartlc acid or a cysteine mdlcatmg the importance of a negative charge at this 
position. 
Neutral endopeptldase-24.1 I; Zinc-bmdmg site: Catalytic mechanism 
1. INTRODUCTION 
The zinc-dependent hydrolase neutral endopeptidase- 
24.11 (EC 3.4.24.11, NEP; neprilysin, CD 10, CALLA) 
is a mammalian plasma membrane ectoenzyme [l]. 
NEP is distributed in many tissues including kidney and 
intestinal microvilli, the central nervous system, and the 
immune system. NEP is involved in the extracellular 
catabolism of biologically active peptides. According to 
their antinociceptive and antihypertensive properties, 
NEP inhibitors are of great interest [2]. 
NEP is a member of a zinc-metalloprotease family 
comprising among others the bacterial thermolysin (EC 
3.4.24.4, TLN) which is the best characterized [3]. They 
all contain in their active site the conserved motif 
HExxH in which the Glu residue participates as a gen- 
eral base in the catalytic mechanism and the two His 
residues coordinate the zinc atom [4]. Among the mem- 
bers of this family NEP seems to be the most related to 
TLN; indeed both enzymes cleave peptide bonds on the 
amino side of hydrophobic residues. Moreover, NEP 
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Abbreviatmns B,,,,,. maxlmum binding; NEP. neutral endopeptldase- 
24.11, CALLA, common acute lymphoblastic leukemia antigen: 
octylglucoside, N-octyl-p-D-glucopyranoslde: HACBO-Gly. N- 
[(2RS)-3-hydroxyam~nocarbonyl-2-benzy~-l-oxopropyI]-glycine; 
MES. 2-(morpholmo)ethanesulfonic acid: TBS, Trls-buffered sahne 
and TLN are equally sensitive to inhibition by phospho- 
ramidon [5] and the NEP inhibitors thiorphan and 
retro-thiorphan which inhibit both enzymes with the 
same stereochemical dependence have been co-crystal- 
lized with TLN [6.7]. Finally, despite little overall ho- 
mology between the primary structures of both enzymes 
[8] most of the already characterized amino acid resi- 
dues located in the active site of NEP have their coun- 
terpart in TLN. Indeed, in addition to the amino acid 
residues of the common HExxH sequence. GII.+“~ which 
has been shown to be the third zinc ligand of NEP is 
equivalent to G1ulhh in TLN [9]. Similarly. His’l’ of 
NEP involved in the stabilization of the tetrahedral in- 
termediate during the transition state is analogous to 
Hi?’ in TLN [ IO,1 I]. Finally, Va15*” and Arg7j7 of NEP 
involved in substrate binding are equivalent in TLN to 
Va1’39 and ArgzU3, respectively [ 12,131. 
Zinc ions can take on a regulatory, structural, or 
catalytic role in enzymes. X-ray diffraction studies have 
allowed the characterization of structural and catalytic 
zinc-binding sites. In all analyzed enzymes a structural 
zinc atom is coordinated to four cysteine residues, 
whereas a catalytic zinc atom is coordinated to three 
amino acid residues and an activated water molecule 
[14.15]. In both cases the coordination is that of a dis- 
torted tetrahedron. The major zinc-binding amino acid 
side chains for catalytic zinc ions are imidazole (His), 
carboxyl (Asp, Glu) and thiol (Cys). In the present 
study we assess the performance of potential metal- 
coordinating residues (His, Asp, Glu, Cys, Ser and Tyr) 
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[16] in the context of the zinc-binding site of NEP. Our 
biochemical data provides further information on zinc- 
binding in a structural and functional perspective. 
2. EXPERIMENTAL 
2.1. Vector construction and site-dtrected mutagenesis 
A 3,868 bp DNA fragment (HindIlI-BarnHI) from the already 
described expression vector pSVENK19 [17] was introduced m 
M13mp19 RF DNA. Using site-directed mutagenests on single- 
stranded DNA [18] the sequence CTGCAG recognized by PstI was 
changed to CTGCAT. This silent mutatton did not modify the ammo 
acid sequence of NEP. A 3.100 bp DNA fragment (BstEII-BarnHI) 
containing the mutated region was then reintroduced m pSVENK19 
to generate pSVENK20. These manipulations will allow us to use a 
663 bp DNA fragment (PstI-BstEII) as a cassette for mutagenesis 
usmg PCR procedures. 
Mutagenesis by PCR was performed according to the procedure 
described in [19] using the pfuTaq polymerase (Stratagene. Palo Alto). 
The PCR product was purified from agarose gel. then precipitated in 
95% ethanol containing 2% potassium acetate and digested by PstI 
and BstEII. The 663 bp DNA fragment (PstI-BstEII) containing the 
mutated region was substituted for the equivalent non-mutated frag- 
ment in pSVENK20. The presence of the mutations and the absence 
of non-specific mutations m the expression vectors were confirmed by 
sequencing the 663 bp mutated region. 
2.2. Transfection of COS-I cells. bmdmg of /‘-“I].?Bl2 monoclonal 
antibody and [-‘H]HACBO-Gly to COS-1 cells 
Wild-type and mutated enzymes were obtained by transient expres- 
sion m COS-1 cells as previously described in [9]. The bmding of 
[‘251]2B12 monoclonal antibody [20] was performed on intact trans- 
fected cells as described previously [21], and was used to monitor cell 
surface expression of NEP. The radiolabelled Inhibitor [‘HIHACBO- 
Gly (30 Ci/mmol) [22] was synthesized in the laboratory of B.P. Ro- 
ques (Paris) and tritiated at the Commissariat g I’Energie Atomique 
(Gif-sur-Yvette. France). Inhibitor binding was performed as de- 
scribed in [9] except that cells were dissolved in Solvable (New-Eng- 
land Nuclear) and radioactivity was measured usmg Formula-989 
(New-England Nuclear) B,,, values were determined after quantita- 
tion of soluble extracts by immunoblottmg. 
2.3. Enzyme assays and immunoblotting 
NEP was solubilized in TBS containing 1% octylglucostde [9]. The 
activity of NEP in the extracts was measured using the tritiated sub- 
strate (tyrosyl-[3,5-3H])(o-Ala,)-Leu-enkephalin (50 Cilmmol) (Re- 
search Product International Inc.. Mount Prospect, IL) as previously 
described [9] except that incubations were carried out in 50 mM MES, 
pH 6.5, at 37°C. All enzymatic assays were performed under mitral 
velocity conditions. The concentration of wild-type or mutated en- 
zymes was determined by immunoblottmg using purified rabbit kid- 
ney NEP as a standard as described in [9] except that the bands were 
visualized using the ECL System from Amersham. The sensitivity of 
the non-mutated and mutated enzymes towards HACBO-Gly and 
l,lO-phenanthrohne were determmed from dose-response curves. In 
the case of competitive mhibitton, K, values corresponded to the IC,, 
values, since the concentration of substrate (50 nM) was well below 
the K,,, value. 
3. RESULTS 
3.1. Expression of recombinant enzymes 
Wild-type and mutant plasmids were transiently ex- 
pressed in COS-1 cells. All the recombinant proteins 
were recognized at the cell surface by the [“‘1]2B12 
monoclonal antibody (data not shown). Moreover, im- 
munoblot analysis of cell extracts showed that the mu- 
tant enzymes had molecular weights very similar to that 
of the non-mutated recombinant enzyme (94 kDa) (data 
not shown). These results indicate that the mutant en- 
zymes are expressed at the cell surface as efficiently as 
the non-mutated enzyme and are fully glycosylated. 
3.2. Mutations of HisSR3 or Hida 
Both histidine residues belong to the canonic se- 
quence HExxH. Substitutions at positions 583 or 587 
had dramatic effects on enzymatic activity: none of the 
mutants had significant enzymatic activity in the condi- 
tions of the assay (Table I). This lack of activity might 
be the consequence of a decreased affinity for the zinc 
ion. To test this hypothesis, ZnCl, at concentrations 
ranging from lo-* to 10m3 M was added in the incuba- 
tion buffer. The addition of ZnCl, did not reactivate 
mutant enzymes. Binding experiments using 10 nM 
[3H]HACBO-Gly were also performed on the mutant 
enzymes in the absence or in the presence of added 
ZnCl, to test for the presence of the zinc ion in the active 
site. Indeed, when it is used in a nanomolar range of 
concentrations this potent inhibitor of NEP is strictly 
dependent on the presence of a well-positioned zinc ion 
in the active site of the enzyme for binding [22,23]. In 
absence of exogenous zinc G~u~‘~ NEP was the only 
mutant able to significantly bind the tritiated inhibitor. 
As shown in Fig. 1, binding was enhanced by addition 
of ZnCl, up to 10m6 M. Higher zinc concentrations led 
to a decrease in inhibitor binding which was also ob- 
Table I 
Properties of mutated and non-mutated enzymes 
Enzymes 
Hls5*’ NEP 
Cys”’ NEP 
Asp’= NEP 
Gh?* NEP 
Tyr5*’ NEP 
Enzymatic activity Inhibitor binding 
+ + 
- +d 
- _ 
- 
_ 
His’*’ NEP 
Cyss8’ NEP 
Asp 5H7 NEP 
G1u5s7 NEP 
Tyr5s7 NEP 
+ + 
- - 
_ - 
+ 
- _ 
GluMb NEP + + 
Asp@” NEP + + 
Cys@” NEP + + 
HtsM6 NEP _ 
Tyrw6 NEP - - 
Serb4h NEP _ 
Enzymatic activity was determined with the tritiated substrate (D- 
Alaz)Leu-enkephahn and inhibitor binding experiments were per- 
formed with the tritiated competitive inhtbttor [‘HIHACBO-Gly. 
“This mutant bound the trmated inhibitor only in presence of ex- 
ogenous zmc 
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NO 1o-8 lo-' 1o-6 10-O lo-* 1o-3 
ZnClz (M) 
Fig. I, Bmding of [‘HIHACBO-Gly to GIuTX7 and Cy?” NEPs. Bind- 
ing was performed as described m section 2 usmg IO nM of the tritlated 
inhibitor. Increasing amounts of ZnCl, were added to the mcubatlon 
medium. Open bars = GIL?’ NEP; hatched bars = CysL”’ NEP 
served for wild-type NEP (data not shown). Maximum 
binding for Glusx7 NEP was only 6% of the binding 
observed with the non-mutated enzyme. Cys”’ NEP 
was also able to bind the tritiated inhibitor but only in 
the presence of additional zinc and showed a maximal 
binding at 10m5 M ZnCl, (Fig. 1). In these conditions 
this binding represented 7.5% of the wild-type binding. 
These results are consistent with a decrease in affinity 
of these two mutated proteins for the zinc ion. However, 
the absence of saturation for inhibitor binding did not 
allow us to determine significant binding parameters. 
3.3. Mutatiom of GldJ6 
Mutations affecting G~u~-‘~ of NEP are less drastic 
with regard to the catalytic activity. Indeed. in addition 
to Asp@6 NEP which was characterized previously [9]. 
Cys646 NEP showed a substantial activity in absence of 
exogenous zinc (Table I). Addition of zinc up to a con- 
centration of 10m6 M did not enhance activity of the 
mutant enzymes, but higher concentrations of ZnCl, 
decreased enzymatic activity as observed for the wild- 
type enzyme (results not shown). This inhibition of en- 
600 r 
0 1000 2000 3000 4000 5000 
BOUND (nmole/mg NEP) 
Fig. 2. Scatchard plots of [7H]HACBO-Gly bmdmg to non-mutated 
and mutated NEPs. Bmding was performed as described in sectlon 2. 
Kd and B,.,, values (see text) were deduced from the slopes and are the 
mean of three Independent experiments. FIlled circles = non-mutated 
NEP: open circles = Asp”” NEP: filled triangles = Cysh” NEP. 
zymatic activity already observed for the renal enzyme 
[24] might be attributed to the presence of a putative 
inhibitory zinc-binding site as proposed for car- 
boxypeptidase A [Xl. Kinetic parameters were meas- 
ured for Asp646 NEP and Cys6jh NEP. Table II shows 
that the ‘O-fold decrease in specific activity (k,,,lK,,,) for 
both mutants is fully accounted for a decrease in k,,,. 
That the K,,, values for both mutants are very similar to 
that of the non-mutated enzyme suggest that the struc- 
ture of the active site has not been grossly altered by 
these mutations. This hypothesis is supported by a sim- 
ilar sensitivity of the mutant and non-mutated enzymes 
to HACBO-Gly (Table II). However, both mutant en- 
zymes exhibited a higher susceptibility to inhibition by 
the chelating agent l,lO-phenanthroline than the non- 
mutated enzyme (Table II), suggesting a slightly re- 
duced affinity of both mutants for the zinc ion. To 
confirm the presence of a well-positioned zinc ion in the 
active site of Asphd6 NEP and Cyshd6 NEP, we per- 
formed binding experiments using [‘HIHACBO-Gly in 
absence of exogenous zinc. Binding parameters were 
determined from Scatchard plots (Fig. 2). Kd values 
Table II 
Kinetic parameters of mutated and non-mutated enzymes 
Enzymes k,, 
(mn-‘) 
K,” IC,,,b 
(nM) luM) 
Wild-type NEP 44 f 5 700 k 35 16 3kl 89 f 8 
AspM6 NEP 42 f 5 36 k 10 0.85 822 1924 
CysWh NEP 50 t 6 402 2 o.so 5*1 l4k 1 
K,,, and k,,, values are the mean of three determinations performed as described m sectlon 2.5. 
‘K, values are for the Inhibitor HACBO-Gly. 
bIC,,, values are for l.lO-phenanthroline 
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A 
T 
Fig. 3. Zinc-binding sites of several zinc-enzymes (A) Thermolysm 
(PDB 3TLN entry). zmc bemg coordmated to two htsttdine residues, 
a glutamic acid residue and a water molecule [3]. (B) Carboxypepti- 
dase A (PDB SCPA entry). zmc being coordinated to two histidme 
resrdues, a glutamic acid restdue and a water molecule [30]. (C) Alco- 
hol dehydrogenase (PDB 8ADH entry), zinc being coordmated to two 
cysteine residues, a histtdme residue and a water molecule [31]. (D) 
Carbonic anhydrase (PDB XAB entry). zmc bemg coordmated to 
three htsttdine residues and a water molecule [29] 
were found to be 10 + 1.5 nM and 12 + 1 nM for AspbJ6 
NEP and Cys646 NEP, respectively. These values are 
similar to that determined for the non-mutated enzyme 
(8 + 1 nM). On the other hand. B,,, values were very 
different for both mutants since they were estimated to 
be 4,270 + 440 nmol/mg NEP and 755 f. 45 nmol/mg 
NEP for AS~~~” NEP and Cysjd6 NEP, respectively. B,,, 
value for CYS@~ NEP was 5 times lower than that of the 
non-mutated enzyme (4,600 + 350 nmol/mg NEP) indi- 
cating that only a portion of the molecules bound the 
tritiated inhibitor. Addition of zinc up to 10e6 M did not 
enhance [3H]HACBO-Gly binding for wild-type enzyme 
nor for the mutant enzymes, but higher zinc concentra- 
tions decreased this binding (results not shown). 
4. DISCUSSION 
X-ray diffraction studies of zinc-metallopeptidases 
and other zinc-enzymes have shown that different 
amino acid side chains can act as ligands of catalytic 
zinc ions (Fig. 3) [26]. In the present study, we have 
evaluated the possibility that other amino acid side 
chains could replace the three zinc ligands of NEP. The 
choice of the amino acid residues in the substituted 
positions was dictated by their presence in the metal- 
binding site of other zinc-enzymes. 
All substitutions performed at positions 583 and 587 
resulted in inactive enzymes. However, two of the mu- 
tant enzymes, Cy?’ NEP and Glu5” NEP, bound par- 
tially [3H]HACBO-Gly which is dependent on the pres- 
ence of zinc in the active site for binding. Given the 
small amounts of recombinant enzymes it has not been 
possible to verify the presence of the zinc ion by direct 
chemical or isotopic methods. The lack of [3H]HACBO- 
Gly binding observed for other mutant enzymes does 
not necessarily mean that zinc ion is absent from the 
active site. Indeed, zinc binding with a very low affinity 
or in a position preventing interaction with the hy- 
droxamate group of the inhibitor may also result in the 
absence of [“HIHACBO-Gly binding. That CY?*~ NEP 
and Glt?’ NEP are inactive despite their ability to bind 
partially the zinc ion can be explained by several non- 
exclusive hypotheses: (1) mutations introduced a distor- 
tion in the putative a-helix containing the motif HExxH 
and consequently a small change in the spatial position 
of the neighbouring G~u’*~ which is essential for cata- 
lytic activity [ 171; (2) Glu’*’ and Cyssx3 side chains which 
can simultaneously coordinate the zinc atom and accept 
hydrogen bonds [27] form a hydrogen bond with the 
zinc-coordinated water molecule. thus changing its spa- 
tial location and consequently preventing nucleophilic 
attack of the substrate; (3) the decrease in affinity for 
zinc could reflect a small change in the spatial position 
of the zinc ion itself that could prevent polarization of 
the carbonyl group of the substrate that is the fifth zinc 
ligand during catalysis [3]. Thus, substitutions at posi- 
tions 583 and 587 suggest that histidine residues at these 
two positions are strictly required for the activity of the 
enzyme. 
The situation is somehow different at position 646 
since both Asp646 NEP and CYS~“~ NEP exhibited some 
activity. Km values for the substrate and K,, values for 
[“HIHACBO-Gly are similar to that of the non-mutated 
enzyme indicating that these mutations do not induce 
a gross alteration of the active site of these enzymes. 
However, the slower rate of substrate hydrolysis and the 
higher sensitivity to the chelating agent 1 .lO-phenan- 
throline observed for both mutants can be explained by 
a small displacement of the zinc ion resulting from the 
mutations, as discussed previously [9]. The 5-fold de- 
crease in B,,, for C~S’~~ NEP in comparison with both 
Aspb4(’ NEP and the wild-type enzyme suggests hetero- 
geneity of the Cys@’ mutant enzymes. Indeed, only 20% 
of Cys6j6 NEP molecules were able to bind the tritiated 
inhibitor. The remaining molecules could be structur- 
ally altered by the formation of a non-native disulfide 
bridge involving Cys . ‘a Thus if one takes into account , 
the proportion of Cys”j6 NEP able to bind the tritiated 
inhibitor, the k,,,lK,,, value should decrease 4-fold only 
rather than 20-fold. This observation indicates that cys- 
teine is a better ligand for zinc than aspartic acid at 
position 646 of NEP. Furthermore, it confirms the 
greater ability for thiolate than carboxylate to coordi- 
nate the zinc ion [28]. It is important to note that a 
negatively charged ligand is necessary at position 646 
for zinc-coordination. Indeed, both aspartate and gluta- 
mate are negatively charged residues and the thiol side 
chain of cysteine is also negatively charged as it com- 
plexes a metal ion in a protein [27]. The nature of the 
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zinc ligands in His 646 NEP is identical to that found 
in carbonic anhydrase (CA) (Fig. 3D). However, this 
NEP mutant was both inactive and unable to bind the 
tritiated inhibitor suggesting that GIu6j6 of NEP cannot 
be replaced by a histidine residue. This observation can 
best be explained by the fact that the three zinc ligands 
are not in the same structural context in NEP and CA. 
Indeed, the three zinc ligands of TLN and probably of 
NEP are on two adjacent a-helices, whereas the three 
equivalent residues of CA are on two adjacent P-strands 
[29]. However, the zinc-binding site of NEP and CA 
share common features since they are characterized by 
a short spacing between the first two ligands, a longer 
spacing between the second and the third ligand, and 
probably a distorted tetrahedral geometry [ 141. 
Taken together, our results suggest that in the context 
of NEP a histidine ligand can neither be replaced effi- 
ciently by another potential ligand nor replace the Glu 
residue as ligand. This is in good agreement with the 
unique structural features of the histidine side chain that 
is characterized by its conformational rigidity and the 
possibility of hydrogen bonding for the nitrogen atom 
of the imidazole ring not involved in zinc-binding [27]. 
On the other hand, that an aspartic or a cysteine can 
replace a glutamic acid can be explained by the relative 
similarity of their side chain. 
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